Anaptysbio ANAB
NASDAQ ANAB
$47.94 +2.51 (+5.52%)
At close: Oct 21, 2026 · 4:00 PM EDT

Anaptysbio (ANAB) Deferred Taxes (2025)

Updated

Anaptysbio (ANAB) recorded Deferred Taxes of -$3.54 million in Q1 2025.

Analysis

Anaptysbio (ANAB) Deferred Taxes (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -479.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -195.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -587.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.32 Bn
10 Anaptysbio 1.37 Bn 260.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 3.54 Mn
API Access

Anaptysbio Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=ANAB&period=max&api_key=YOUR_API_KEY